NCT00344994View on ClinicalTrials.gov

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2010

Conditions
Restless Legs Syndrome
Interventions
DRUG

pramipexole

PO, 0.25mg, 0.50mg, or 0.75mg QHS

Trial Locations (1)

30912

Medical College of Georgia, Augusta

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Augusta University

OTHER